These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 4802715)

  • 21. [Immunodepressant drugs in the pathogenetic therapy of infectious non-specific polyarthritis].
    Astapenko MG
    Vopr Revm; 1972; 12(3):39-45. PubMed ID: 4664819
    [No Abstract]   [Full Text] [Related]  

  • 22. Prospective pilot study of intravenous pulse cyclophosphamide therapy for refractory rheumatoid arthritis.
    Arnold MH; Janssen B; Schrieber L; Brooks PM
    Arthritis Rheum; 1989 Jul; 32(7):933-4. PubMed ID: 2751725
    [No Abstract]   [Full Text] [Related]  

  • 23. [Immunosuppressive therapy in primary chronic polyarthritis].
    Warnatz H
    Verh Dtsch Ges Inn Med; 1972; 78():771-4. PubMed ID: 4665752
    [No Abstract]   [Full Text] [Related]  

  • 24. Intravenous cyclophosphamide pulses in the treatment of pyoderma gangrenosum associated with rheumatoid arthritis: report of 2 cases and review of the literature.
    Zonana-Nacach A; Jiménez-Balderas FJ; Martínez-Osuna P; Mintz G
    J Rheumatol; 1994 Jul; 21(7):1352-6. PubMed ID: 7966084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunosuppression and rheumatoid arthritis.
    Roberts SD
    Ir Med J; 1975 Jun; Suppl():21-8. PubMed ID: 1181323
    [No Abstract]   [Full Text] [Related]  

  • 26. Factor VIII antibodies in rheumatoid arthritis. Effect of cyclophosphamide.
    Green D; Schuette PT; Wallace WH
    Arch Intern Med; 1980 Sep; 140(9):1232-5. PubMed ID: 6773487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Our experience of chronic rheumatic polyarthritis therapy with immunosuppressive agents. Apropos of 41 cases].
    Arlet J; Mole J; Debrock J
    Rev Rhum Mal Osteoartic; 1971 Dec; 38(12):771-4. PubMed ID: 5152709
    [No Abstract]   [Full Text] [Related]  

  • 28. [Immunosuppressive therapy with antineoplastic agents in rheumatoid arthritis].
    Fantini F; Cirla E; Tosi S; Solazzi F; Chériè Lignière G; Colombo B
    Reumatismo; 1970; 22(1):Suppl:96-117. PubMed ID: 5524874
    [No Abstract]   [Full Text] [Related]  

  • 29. Peripheral ulcerative keratitis in rheumatoid arthritis: successful use of intravenous cyclophosphamide and comparison of clinical and serological characteristics.
    Clewes AR; Dawson JK; Kaye S; Bucknall RC
    Ann Rheum Dis; 2005 Jun; 64(6):961-2. PubMed ID: 15897315
    [No Abstract]   [Full Text] [Related]  

  • 30. Paraneoplastic arthritis may mimic rheumatoid arthritis with symmetrical and upper extremity predilecting presentation.
    Bahat G; Kamali S; Saka B; Erten N; Karan MA; Tascioglu C
    J Clin Rheumatol; 2009 Sep; 15(6):319-20. PubMed ID: 19734744
    [No Abstract]   [Full Text] [Related]  

  • 31. [Long term treatment of progressive polyarthritis with cyclophosphamide].
    Klabusay L; Duda V
    Vnitr Lek; 1969 Nov; 15(11):1113-8. PubMed ID: 4983404
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cyclophosphamide in severe rheumatoid polyarthritis. Results from a preliminary trial on 10 cases].
    Auquier L; Henrard JC; Siaud JR
    Rev Rhum Mal Osteoartic; 1971 Dec; 38(12):775-9. PubMed ID: 5152710
    [No Abstract]   [Full Text] [Related]  

  • 33. [Cyclophosphamide in rheumatoid polyarthritis. Clinical study. 45 cases. Seven year follow-up].
    Chaouat Y; Kanovitch B; Paquet J; Pélisson J; Rascovscki S; Faures B
    Rev Rhum Mal Osteoartic; 1971 Dec; 38(12):751-8. PubMed ID: 5152706
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cyclophosphamide in the therapy of rheumatoid arthritis and its complications].
    Trefler J; Matyska-Piekarska E; Łacki JK
    Pol Merkur Lekarski; 2007 Jun; 22(132):566-70. PubMed ID: 17874631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunosuppressive treatment of progressive chronic polyarthritis].
    Seidel R; Reissmann K; Land H; Rödel J
    Z Gesamte Inn Med; 1975 Aug; 30(16):535-8. PubMed ID: 1189506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Our experience in the immunodepressive treatment of rheumatoid polyarthritis].
    Bied JC; Faivre J; Dury JL
    Lyon Med; 1971 Sep; 226(14):183-9. PubMed ID: 5117724
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical aspects of the use of cytostatic substances in rheumatoid arthritis].
    Benenson EV; Levin AI
    Ter Arkh; 1973 Jan; 45(1):45-50. PubMed ID: 4770020
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of rheumatoid arthritis with immunosuppressive agents. Review of literature and personal cases. Results in 45 patients treated with cyclophosphamide for 6 years].
    Frizziero L; Zizzi F; Facchini A; Zini G; Ferruzzi A; Mariani E
    Recenti Prog Med; 1981 Dec; 71(6):612-40. PubMed ID: 7041209
    [No Abstract]   [Full Text] [Related]  

  • 39. Does cyclophosphamide combined with methylprednisolone affect the expression of leukocyte function associated antigen 1 in refractory rheumatoid arthritis.
    Lacki JK; Müller-Ruchholtz W; Mackiewicz SH
    Arch Immunol Ther Exp (Warsz); 1997; 45(4):285-8. PubMed ID: 9523002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The results of treatment of far-advanced highly active forms of rheumatoid arthritis with immunosuppressive agents: proresid and endoxan.
    Wawrzyńska-Pagowska J; Juszczyk T; Michalski J; Wójcik-Scislowska M
    Reumatologia; 1970; 8(4):289-97. PubMed ID: 5533055
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.